In conclusion, our research demonstrated that WXJ-202 induced apoptosis and cycle arrest through affected CDK4/6-Rb-E2F pathway-associated proteins, producing antitumor effects on breast cancer cells in vitro and in vivo. This evidence concerns the gene CDK4 and breast cancer.